All 4 studies (177 vitiligo patients versus 82 controls) on circulating CXCL12 in vitiligo reported increased values in vitiligo patients compared to controls, resulting in a highly significant P-value of the meta-analysis (P = 0.003) (15, 19, 25, 33). The gene discussed is CXCL12; the disease is vitiligo.